PFS
NVS icon

Penseco Financial Services’s Novartis NVS Stock Holding History

Penseco Financial Services’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$263K Sell
3,819
-94
-2% -$6.22K 0.19% 90
2013
Q2 		$248K Buy
+3,913
New +$255K 0.19% 91

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Penseco Financial Services's NVS Position: Q3 2013 in Review

Penseco Financial Services reduced its Novartis (NVS) stake by 2.4% in Q3 2013, selling an estimated $6.22K and leaving 3,819 shares worth $263K. The position accounts for 0.19% of the portfolio, ranked #90.

Penseco Financial Services first reported a position in NVS in Q2 2013 and has held it in 2 quarters since. 761 funds tracked by Wall St. Rank hold NVS as of Q3 2013.

  • Penseco Financial Services held 3,819 shares of Novartis worth $263K as of Q3 2013.
  • Penseco Financial Services sold 94 Novartis shares in Q3 2013, an estimated $6.22K.
  • Novartis made up 0.19% of Penseco Financial Services's portfolio in Q3 2013, its #90 holding.
  • Penseco Financial Services first reported a position in Novartis in Q2 2013 and has held it in 2 quarters since.
  • 761 funds tracked by Wall St. Rank held Novartis as of Q3 2013.

Based on Penseco Financial Services's 13F filing for Q3 2013, filed 4 Oct 2013.